OSUR

+ Watchlist + Portfolio

OraSure Technologies, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $3.70
52-Week Range: $2.08 – $4.58
Market Cap: $257.94M
P/E (TTM): —
EPS (TTM): -0.70
Dividend Yield: —

Advanced Metrics

Price/Book: 0.83
PEG Ratio: 6.19
Return on Equity: -14.07%
Return on Assets: -11.04%
Gross Margin: 42.63%
Operating Margin: -55.98%
Profit Margin: -43.70%
Current Ratio: 8.88
Debt/Equity: 0.04
Total Debt: $12.09M
Free Cash Flow: $-44.57M
Revenue Growth: -1.90%
Earnings Growth: —
Enterprise Value: $109.45M

OSUR Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$387.48M	$405.47M	$185.83M	$115.02M
Cost of Revenue	$239.04M	$233.82M	$106.44M	$66.82M
Gross Profit	$148.44M	$171.65M	$79.39M	$48.20M
Research & Development	$36.24M	$33.73M	$26.05M	$42.53M
Selling, General & Admin	$117.44M	$94.51M	$77.20M	$73.79M
Operating Expenses	$153.68M	$128.24M	$103.25M	$116.32M
Operating Income	-$5.24M	$43.41M	-$23.86M	-$68.12M
EBITDA	$10.29M	$64.35M	-$13.55M	-$58.15M
Pretax Income	-$15.68M	$56.26M	-$16.00M	-$64.59M
Income Tax	$1.46M	$2.60M	$1.80M	$1.80M
Net Income	-$17.13M	$53.66M	-$19.50M	-$68.73M
Diluted EPS	-0.25	0.72	-0.26	-0.94
Diluted Shares	72.50M	74.39M	74.43M	73.48M

OSUR Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$83.98M	$290.41M	$267.76M	$199.28M
Receivables	$70.80M	$40.17M	$23.82M	$22.20M
Inventory	$95.70M	$47.61M	$34.20M	$31.06M
Current Assets	$325.19M	$386.46M	$333.22M	$261.91M
Total Assets	$444.18M	$482.85M	$479.66M	$403.17M
Current Liabilities	$69.06M	$39.54M	$33.48M	$39.80M
Total Debt	$12.55M	$13.50M	$14.60M	$13.20M
Total Liabilities	$79.75M	$52.17M	$69.32M	$62.34M
Retained Earnings	-$137.59M	-$83.93M	-$103.43M	-$172.16M
Shareholders' Equity	$364.43M	$430.67M	$410.34M	$340.83M
Working Capital	$256.13M	$346.92M	$299.74M	$222.11M

OSUR Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$47.20M	$141.58M	$27.37M	-$49.02M
Capital Expenditure	-$63.91M	-$10.30M	-$3.80M	-$4.20M
Free Cash Flow	-$111.11M	$131.28M	$23.58M	-$53.22M
Depreciation & Amortisation	$15.54M	$20.94M	$10.31M	$9.97M
Stock-Based Compensation	$11.62M	$10.73M	$11.92M	$10.15M
Investing Cash Flow	$21.09M	$66.15M	-$39.03M	-$6.81M
Financing Cash Flow	-$3.83M	-$3.02M	-$4.18M	-$16.94M
Share Repurchases	-$2.25M	-$1.90M	-$3.55M	-$16.88M
Net Change in Cash	-$29.95M	$204.71M	-$15.83M	-$72.78M

OSUR Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$29.93M	$31.24M	$27.09M	$26.76M	$27.93M
Cost of Revenue	$17.63M	$18.08M	$15.31M	$15.79M	$16.12M
Gross Profit	$12.30M	$13.16M	$11.77M	$10.97M	$11.80M
Research & Development	$9.60M	$11.40M	$10.11M	$11.42M	$13.65M
Selling, General & Admin	$20.96M	$19.05M	$16.49M	$19.12M	$21.33M
Operating Expenses	$30.56M	$30.45M	$27.49M	$27.82M	$34.98M
Operating Income	-$18.27M	-$17.29M	-$15.71M	-$16.85M	-$23.18M
EBITDA	-$15.49M	-$14.88M	-$13.33M	-$14.45M	-$20.92M
Pretax Income	-$15.97M	-$16.89M	-$13.29M	-$18.43M	-$21.72M
Income Tax	-$456.00K	$2.00M	$47.00K	$210.00K	-$432.00K
Net Income	-$16.04M	-$19.69M	-$13.71M	-$19.29M	-$22.38M
Diluted EPS	-0.21	-0.26	-0.19	-0.27	-0.32
Diluted Shares	74.87M	74.54M	73.00M	71.57M	69.67M

OSUR Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$247.57M	$234.58M	$216.48M	$199.28M	$176.96M
Receivables	$21.52M	$25.90M	$24.30M	$22.20M	$26.41M
Inventory	$35.68M	$33.38M	$33.40M	$31.06M	$30.31M
Current Assets	$313.78M	$301.44M	$283.01M	$261.91M	$240.78M
Total Assets	$457.61M	$445.04M	$423.10M	$403.17M	$379.17M
Current Liabilities	$25.42M	$42.35M	$40.25M	$39.80M	$44.08M
Total Debt	$14.20M	$14.13M	$13.46M	$13.20M	$12.66M
Total Liabilities	$61.33M	$64.31M	$61.12M	$62.34M	$65.84M
Retained Earnings	-$119.47M	-$139.16M	-$152.88M	-$172.16M	-$194.54M
Shareholders' Equity	$396.28M	$380.72M	$361.98M	$340.83M	$313.32M
Working Capital	$288.36M	$259.09M	$242.76M	$222.11M	$196.70M

OSUR Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$19.73M	-$10.22M	-$10.07M	-$9.00M	-$13.89M
Capital Expenditure	-$420.00K	-$1.94M	-$919.00K	-$922.00K	-$913.00K
Free Cash Flow	-$20.15M	-$12.16M	-$10.99M	-$9.92M	-$14.81M
Depreciation & Amortisation	$2.77M	$2.42M	$2.38M	$2.40M	$2.26M
Stock-Based Compensation	$2.69M	$3.17M	$2.83M	$1.46M	$2.77M
Investing Cash Flow	$370.00K	-$1.94M	-$821.00K	-$4.42M	-$913.00K
Financing Cash Flow	-$953.00K	-$5.80M	-$5.08M	-$5.11M	-$6.28M
Share Repurchases	-$941.00K	-$4.06M	-$5.00M	-$6.88M	-$6.26M
Net Change in Cash	-$20.32M	-$17.96M	-$15.97M	-$18.53M	-$21.09M

Market Snapshot

About

OraSure Technologies, Inc. develops and manufactures diagnostic products and specimen collection devices using oral fluid samples. The company offers rapid point-of-care tests for infectious diseases including HIV, HCV, and COVID-19, as well as molecular collection systems. OraSure focuses on non-invasive diagnostic solutions that provide accurate results and improve patient convenience.